1. Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate‐to‐severe plaque psoriasis – nationwide results from the DERMBIO registry. (29th March 2017) Authors: Egeberg, A.; Iversen, L.; Gniadecki, R.; Hvid, L.; Dam, T.N.; Bryld, L.E.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 7(2017) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study. (12th April 2022) Authors: Loft, N.; Egeberg, A.; Rasmussen, M.K.; Bryld, L.E.; Nissen, C.V.; Dam, T.N.; Ajgeiy, K.K.; Iversen, L.; Skov, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 8(2022) Page Start: 1284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (9th January 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety, efficacy, and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (14th February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, efficacy, and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. (1st February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Systemic psoriasis therapy shows high between‐country variation: a sign of unwarranted variation? Cross‐sectional analysis of baseline data from the PSONET registries. (30th August 2013) Authors: Garcia‐Doval, I.; Rustenbach, S.J.; Stern, R.; Dam, T.N.; Cohen, A.D.; Baker, C.; Spuls, P.I.; Naldi, L. Journal: British journal of dermatology Issue: Volume 169:Number 3(2013:Sep.) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 生物制剂和生物仿制药对中度至重度斑块状银屑病患者的安全性、疗效和药物存活率. (14th February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 生物制剂和生物仿制药对中度至重度斑块状银屑病患者的安全性、疗效和药物存活率. (1st February 2018) Authors: Egeberg, A.; Ottosen, M.B.; Gniadecki, R.; Broesby‐Olsen, S.; Dam, T.N.; Bryld, L.E.; Rasmussen, M.K.; Skov, L. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗